PATENT CLAIM ANALYSIS

Application Number: 16117107
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "341000"]

Abstract:
The present invention provides compounds of Formula (I): a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, a solvate thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

Claim (Index 21):
A method for the treatment of diabetes, hyperglycemia, impaired glucose tolerance, gestational diabetes, insulin resistance, hyperinsulinemia, nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, Metabolic Syndrome, obesity, dyslipidemia, and/or glaucoma comprising administering to a patient in need of such treatment a therapeutically effective amount of at least a compound according to  claim 7 .

Metadata:
- Claim Count in Document: 56.0
- Percentile: 96.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15866871', '15123773', '15602515', '15618182', '15123791']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8155080767544555
- 35 USC 102 Novelty (BERT): 0.5657642802333356
- Combined Prediction Score: 0.7905336971023434
- Mean Citation Score: 398.53599
- Max Citation Score: 441.1919
- Similarity Product: 426.11625367013215

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test